The greatest organization of women of the world, YWCA summons the Summit the International of Women in Nairobi, Kenya, from the 1 to the 11 of July. This world-wide event without precedents will reunite more than 1500 people, in its majority women, who work actively in diverse sectors to create solutions to the impact that infection VIH and AIDS has on the women and the children. Many of them work in local communities affected by the infection The event that is celebrated in the Center the International of Kenyatta Conference in Nairobi aims to share experiences and evidences so that as much the individuals as the organizations can develop to abilities and knowledge and elaborate effective programs of fight against the disease in concrete realities where usually they are scarce resources and qualified personnel. By their traditional function in the family and by its activism, the women honor how local leaders and are marking to the difference in the fight against the VIH and the AIDS.
The agenda of work of the Summit anticipates the accomplishment of diverse factories and forums on essential subjects like the action on local policies and mechanisms of legal defense, the prevention and the treatments, the cares and support to the infected women and children, the lessons learned in the years of work already developed in the communities. Also Women will give themselves to prizes “Leading the Change” with which tribute to the women will surrender who have led the local work in the prevention areas, taken care of and treatments, defense and formulation of policies of sort equality, estigma and discrimination.
According to the director of the agency of microcedit PlaNet Finance, it is possible to unite the financial services to programs of training and education of the health in areas where infection SIDA/HIV is very high. The women represent most of the beneficiaries of the microcredits and can develop to a central paper in the prevention of the diseases and the maintenance of the health of the family and whole communities. With its program in Morocco, PlaNet Finance wants to demonstrate, in addition, that it is possible to design adapted programs of microfinancing to the special exigencies of the people infected with AIDS/HIV. Posted in AIDS /HIV, banks, economy, microcredit, poverty. Comments “Brazil and Thailandia do not break patents of the pharmaceutical industry May 28, 2007 - MIGAS the Government of Brazil has decided to impose a” obligatory patent “to the drug efavirenz, considered like one of the most effective tools to fight the infection by VIH. Brazil will concern the generic one produced by laboratories of India, that costs less of a third of which it produces the pharmaceutical multinational Merck Sharp&Dhome.
The decision has been answered by the Federation the International of the Industry of the Medicine, that considers that “it is not a solution that improves the access to medicines”. “we are taking an important step and the decision is worth for this remedy and any other when it is necessary. Today he was this one and tomorrow he will be another one. If we did not obtain the right prices, we will make that decision “, has been the answer of the Brazilian president, Luiz Inácio Lula gives Silva. With this measurement the Government of Lula can assure treatment to 75,000 infected.
The Merck multinational receives to the Government of Brazil 1.59 dollars to him by unit of the drug while in Thailand the same drug costs 0.65 dollars the unit. According to the Ministry of Health, the price applied by the laboratories that make the generic one in India is of only 0.45 cents by unit. The annual treatment by patient with the drug of Merck reaches the 580 dollars whereas the same treatment with the generic drug hill 165 dollars to the year, less of a third. The minister of Health, Jose Gomes Temporao, informed that before imposing the obligatory license, the Government of Lula had rejected the offer of Merck to reduce in a 30% the price of the drug, when considering that the reduction of the price had to be at least of 60%. The obligatory license is predicted in the international agreements: it is applied to those patents that fulfill certain conditions and implies that the authorities can grant to license to companies or people different from the holder of the patent so that these make use of the rights of the patent and can make, use, sell or concern a product protected without the permission of the holder of the patent.
Countries such as Italy or Canada also has granted “obligatory licenses” on pharmaceutical products, according to the mechanism anticipated in the Agreement on the Aspects of the Related Rights of Intellectual Property to Comerce, of the World-wide Organization of Commerce. Cheap generic the medicine production based on formulas protected by patent is a practice allowed by the World-wide Organization of Comerce from 2001. In December of 2006 the Government of Thailand announced that he was going to emit a license obligatory to assure that the people infected by VHI could accede to a the generic one of efavirenz, produced by laboratories of India, the same drug that today is object of the obligatory patent emitted by Brazil. In May 2007 Thailand stayed signs as opposed to the pressures of the phamacists, which seems to have opened a breach in the world-wide rules of commerce that could animate to more countries in via of development to break patents in case of emergencies of the public health.
The newness to emphasize is that the Government of the U.S.A. has clarified that Bangkok has not broken any law according to the special dispositions in the Agreement of the OMC on the Aspects of the Rights of Intellectual Property related to Comercio. The office of commercial representation of the United States (USTR) had put to Thailand in a gray list of countries that have violated in some degree the intellectual property and now will have to erase it of the list. Thailand broke the patent of efavirenz imposing an obligatory license, soon did the same with other two drugs for the treatment of patients infected by SIDA-HIV. In the last years, India has become a generic medicine source. According to the humanitarian organization Medical Without Borders, 84% of the medicines that MSF uses to treat the AIDS in more than 30 countries generic are produced in this country. Posted in AIDS /HIV, phamacists, investigation, poverty, intellectual property.